Circle8 Group (CIRC) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Seer (SEER) has outperformed Circle8 Group (CIRC) over the past year, losing 31.0% versus a loss of 94.4%. Over five years, SEER leads with a -94.1% price change compared with -99.9% for CIRC. Seer is the larger company by market cap ($75.9 million vs $16.0 million), about 4.7 times the size.
Circle8 Group converts more of its revenue into profit, with a net margin of -13.6% versus -444.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CIRC | SEER |
|---|---|---|
| Share price | $0.1361 | $1.36 |
| Market cap | $15.99M | $75.91M |
| 1-day change | -12.25% | -1.81% |
| YTD return | -89.77% | -25.68% |
| 1-year return | -94.44% | -30.96% |
| 5-year return | -99.88% | -94.05% |
| EPS (TTM) | $-2.14 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $435.88M | $16.58M |
| Revenue growth (YoY) | -1.52% | +16.99% |
| Net income (latest FY) | $-59.43M | $-73.60M |
| Gross margin | 10.55% | 51.06% |
| Operating margin | -11.52% | -470.45% |
| Net margin | -13.63% | -443.96% |
| 52-week high | $4.56 | $2.38 |
| 52-week low | $0.136 | $1.33 |
| Distance from 52-week high | -97.02% | -42.74% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +194.12% |
| Average volume | 1.13M | 216.28K |
| Shares outstanding | 117.49M | 55.81M |
| Employees | 300 | 124 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Seer is about 4.7 times larger than Circle8 Group by market value ($75.91M vs $15.99M).
- SEER has outperformed CIRC by 63.5 percentage points over the past year.
- Circle8 Group is more profitable, keeping -13.6 cents of every revenue dollar as net income versus -444.0 cents for Seer.
- Seer grew revenue faster in its latest fiscal year (+16.99% vs -1.52%).
About Circle8 Group
CIRC stock →Circle8 Group, Inc. provides talent management services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 300 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
CIRC vs SEER FAQ
Which is bigger, Circle8 Group or Seer?
Seer (SEER) is larger, with a market capitalization of $75.91M compared with $15.99M for Circle8 Group (CIRC).
Which stock has performed better over the past year, CIRC or SEER?
SEER returned -30.96% over the past 12 months, compared with -94.44% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Circle8 Group and Seer in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.